446 related articles for article (PubMed ID: 17360873)
21. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India.
Dua VK; Sharma VP
Ann Trop Med Parasitol; 2001 Oct; 95(7):655-9. PubMed ID: 11784418
[TBL] [Abstract][Full Text] [Related]
24. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
[TBL] [Abstract][Full Text] [Related]
25. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
Shanks GD; Oloo AJ; Aleman GM; Ohrt C; Klotz FW; Braitman D; Horton J; Brueckner R
Clin Infect Dis; 2001 Dec; 33(12):1968-74. PubMed ID: 11700577
[TBL] [Abstract][Full Text] [Related]
26. Single dose tafenoquine for preventing relapse in people with plasmodium vivax malaria-an updated meta-analysis.
Anjum MU; Naveed AK; Mahmood SN; Naveed OK
Travel Med Infect Dis; 2020; 36():101576. PubMed ID: 32036012
[TBL] [Abstract][Full Text] [Related]
27. Relapse pattern of Plasmodium vivax in Mumbai: a study of 283 cases of vivax malaria.
Gogtay NJ; Desai S; Kadam VS; Kamtekar KD; Dalvi SS; Kshirsagar NA
J Assoc Physicians India; 2000 Nov; 48(11):1085-6. PubMed ID: 11310387
[TBL] [Abstract][Full Text] [Related]
28. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys.
Nayar JK; Baker RH; Knight JW; Sullivan JS; Morris CL; Richardson BB; Galland GG; Collins WE
J Parasitol; 1997 Aug; 83(4):739-45. PubMed ID: 9267419
[TBL] [Abstract][Full Text] [Related]
29. Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review.
Duparc S; Chalon S; Miller S; Richardson N; Toovey S
Malar J; 2020 Mar; 19(1):111. PubMed ID: 32169086
[TBL] [Abstract][Full Text] [Related]
30. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
St Jean PL; Xue Z; Carter N; Koh GC; Duparc S; Taylor M; Beaumont C; Llanos-Cuentas A; Rueangweerayut R; Krudsood S; Green JA; Rubio JP
Malar J; 2016 Feb; 15():97. PubMed ID: 26888075
[TBL] [Abstract][Full Text] [Related]
31. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
[TBL] [Abstract][Full Text] [Related]
32. Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand.
Ponsa N; Sattabongkot J; Kittayapong P; Eikarat N; Coleman RE
Am J Trop Med Hyg; 2003 Nov; 69(5):542-7. PubMed ID: 14695093
[TBL] [Abstract][Full Text] [Related]
33. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.
Tasanor O; Ruengweerayut R; Sirichaisinthop J; Congpuong K; Wernsdorfer WH; Na-Bangchang K
Trans R Soc Trop Med Hyg; 2006 May; 100(5):410-8. PubMed ID: 16497347
[TBL] [Abstract][Full Text] [Related]
34. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
35. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
[TBL] [Abstract][Full Text] [Related]
36. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax].
Nicolas X; Granier H; Martin J; Klotz F
Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries.
Naing C; Aung K; Win DK; Wah MJ
Trans R Soc Trop Med Hyg; 2010 Nov; 104(11):695-705. PubMed ID: 20850161
[TBL] [Abstract][Full Text] [Related]
39. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers.
Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
Clin Infect Dis; 1999 Jul; 29(1):199-201. PubMed ID: 10433587
[TBL] [Abstract][Full Text] [Related]
40. Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Sutanto I; Soebandrio A; Ekawati LL; Chand K; Noviyanti R; Satyagraha AW; Subekti D; Santy YW; Crenna-Darusallam C; Instiaty I; Budiman W; Prasetya CB; Lardo S; Elyazar I; Duparc S; Cedar E; Rolfe K; Fernando D; Berni A; Jones S; Kleim JP; Fletcher K; Sharma H; Martin A; Taylor M; Goyal N; Green JA; Tan LK; Baird JK
Lancet Infect Dis; 2023 Oct; 23(10):1153-1163. PubMed ID: 37236221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
